Results 191 to 200 of about 150,306 (248)

Human biomarker navigator

open access: yesiMeta, Volume 5, Issue 5, October 2026.
The Human Biomarker Navigator integrates the disease continuum, biomarker dynamics, cross‐organ biomarker networks, biomarker classification, and technology‐driven paradigms. It maps how biomarkers link multi‐system physiology and pathology across the nervous, respiratory, endocrine, circulatory, immune, digestive, urinary, reproductive, and ...
Meng‐Yao Li   +29 more
wiley   +1 more source

Predictors of durability of the prostatic urethral lift (PUL) for benign prostatic hyperplasia. [PDF]

open access: yesProstate Cancer Prostatic Dis
Eure G   +5 more
europepmc   +1 more source

Assessment of Gold‐Mediated Male Reproductive Dysfunction in Male WISTAR Rats Through Sperm Analysis and Testosterone Measurement

open access: yesJournal of Applied Toxicology, Volume 46, Issue 10, Page 3403-3414, October 2026.
ABSTRACT Gold has been used for centuries in both ornamental and medicinal contexts. More recently, gold compounds, containing ions or nanoparticles, have attracted attention for their anti‐inflammatory, anticancer, and diagnostic applications. Therefore, concerns about systemic toxicity and biodistribution have prompted investigations into the ...
Samira Maghraoui   +2 more
wiley   +1 more source

Elevated Estradiol and DHT Levels in the Prostatic Stroma as Key Drivers of Benign Prostatic Hyperplasia Pathogenesis. [PDF]

open access: yesInt J Mol Sci
Pejčić T   +10 more
europepmc   +1 more source

Technical Feasibility of IVIM for Prostate Cancer Imaging Using High‐Amplitude Whole‐Body Gradient System With Spiral Readout and Velocity‐Compensated Diffusion Encoding

open access: yesNMR in Biomedicine, Volume 39, Issue 10, October 2026.
The combination of velocity‐compensated diffusion encoding, spiral readout and strong gradients enabled high‐quality prostate IVIM imaging, offering a promising framework for the development of reliable IVIM‐based biomarkers for prostate cancer detection, characterisation and monitoring.
Malwina Molendowska   +6 more
wiley   +1 more source

Immune dysregulation in the prostates of C57BL/6Aire−/− mice mirrors that seen in human benign prostatic hyperplasia

open access: yesThe Journal of Pathology, Volume 270, Issue 2, Page 211-225, October 2026.
Abstract Benign prostatic hyperplasia (BPH) is the most common urologic disease in aging men, resulting in significant morbidity. The etiologies of BPH are unknown, though chronic prostatic inflammation is known to promote hyperplasia, fibrotic remodeling, and therapeutic resistance in BPH.
Nadia A Lanman   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy